glp-1 receptor agonist examples Agonists and Other Drugs Glucagon-like peptide-1 (GLP-1) receptor agonists

42 Additionally, claims and EHR data are inherently diverse

28, 2025, semaglutide (Ozempic) received FDA approval to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease) and death due to cardiovascular disease in adults with type 2 diabetes (T2DM) and chronic kidney disease (CKD)

Although the use of GLP-1 RAs prior to EGD or colonoscopy has resulted in poor outcomes in terms of poor visibility/preparation scores and the need for aborted/repeated procedures, one study showed better outcomes with concurrent EGD and colonoscopy

References 1 MalikVSWilletWCHuFB

A strategic approach to weight loss rooted in the latest science is not only superior to antiquated calorie counting, but also capitalizes on the same biological mechanisms responsible for the success of popular weight-loss drugs